Logo

IO Informatics, Partek Renew Software-Integration Agreement

Sep 19, 2007
NEW YORK (GenomeWeb News) — IO Informatics and Partek have renewed a partnership to provide integrated data-management and -analysis software to clients, IO Informatics said yesterday.
 
The agreement renews a 2005 partnership that integrated the Partek Genomics Suite of statistical-analysis and -visualization software with IO’s Sentient Suite of data integration tools for translational medicine and biomarker research.  
  
Under the integration, IO customers will be able to open Sentient within Partek’s Genomics Suite and perform analysis and move results between the two platforms.

Breaking News
The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.